Aytu BioScience's market cap is currently $8.51M. The company's EPS TTM is $-1.446; its P/E ratio is ―; Aytu BioScience is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	$ 81.00M	$ 107.40M	$ 96.67M	$ 65.63M	$ 27.63M
Gross Profit	$ 54.59M	$ 66.63M	$ 52.28M	$ 29.20M	$ 20.08M
Operating Income	$ -5.25M	$ -17.07M	$ 37.22M	$ -38.24M	$ -20.94M
EBITDA	$ -1.01M	$ -3.51M	$ -27.96M	$ -29.04M	$ -12.21M
Net Income	$ -15.84M	$ -17.05M	$ -108.78M	$ -58.29M	$ -13.62M
Balance Sheet
Cash & Short-Term Investments	$ 20.01M	$ 22.98M	$ 19.36M	$ 49.65M	$ 48.08M
Total Assets	$ 118.09M	$ 136.46M	$ 137.62M	$ 265.67M	$ 152.84M
Total Debt	$ 15.13M	$ 16.36M	$ 18.19M	$ 28.35M	$ 2.01M
Net Debt	$ -4.88M	$ -6.62M	$ -1.17M	$ -21.30M	$ -46.07M
Total Liabilities	$ 90.38M	$ 97.11M	$ 91.53M	$ 128.10M	$ 57.82M
Stockholders' Equity	$ 27.72M	$ 39.36M	$ 46.09M	$ 137.57M	$ 95.02M
Cash Flow
Free Cash Flow	$ -1.39M	$ -5.13M	$ -28.82M	$ -28.30M	$ -28.37M
Operating Cash Flow	$ -1.39M	$ -5.13M	$ -28.82M	$ -25.96M	$ -28.37M
Investing Cash Flow	$ -329.00K	$ -117.00K	$ -3.25M	$ -2.78M	$ -5.66M
Financing Cash Flow	$ -1.26M	$ 8.87M	$ 1.53M	$ 30.31M	$ 71.07M

Currency in USD

Aytu BioScience Earnings and Revenue History

Income Statement >

Aytu BioScience Debt to Assets

Balance Sheet >

Aytu BioScience Cash Flow

Cash Flow >

Aytu BioScience Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing